Muscarinic receptor occupancy by biperiden in living human brain

Life Sciences

Volumn 64, Issue 8, 1999, Pages PL99-PL104

  Sudo, Yasuhiko ^a,b,d   Suhara, Tetsuya ^a,d   Suzuki, Kazutoshi ^a   Okubo, Yoshiro ^a   Yoshikawa, Kyosan ^a   Uchida, Sunao ^c   Sassa, Takeshi ^a   Okauchi, Takashi ^a,d   Sasaki, Yasuhito ^a   Matsushita, Masaaki ^b  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Biperiden; Human; Muscarinic cholinergic receptor; Positron emission tomography

Indexed keywords

BIPERIDEN; CHOLINERGIC RECEPTOR; MUSCARINIC RECEPTOR;

ADULT; ARTICLE; BRAIN; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG RECEPTOR BINDING; FRONTAL CORTEX; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY;

EID: 0033556423     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00613-4     Document Type: Article

References (20)

1. L. Farde, F.A. Wiesel, C. Halldin and G. Sedvall, Arch Gen Psychiatry 45 71-6 (1988).
2. L. Farde, A.L. Nordstrom, F.A. Wiesel, S. Pauli, C. Halldin and G. Sedvall, Arch Gen Psychiatry 49 538-44 (1992).
3. S. Kapur, G. Remington, R.B. Zipursky, A.A. Wilson and S. Houle, Life Sci 57 PL103-7 (1995).
4. S. Snyder, D. Greenberg and H. Yamamura, Arch Gen Psychiatry 31 58-61 (1974).
5. M. Sokolovsky, Y. Egozi and Y. Kloog, Monographs in Neural Sciences 7 30-40 (1980).
6. T. Suhara, O. Inoue, K. Kobayashi, K. Suzuki and Y. Tateno, Neurosci Lett 149 225-8 (1993).
7. Y. Sudo, T. Suhara, Y. Honda, K. Suzuki, T. Nakajima, Y. Okubo and K. Yoshikawa, Neurology in press.
8. T. Suhara, O. Inoue, K. Kobayashi, T. Satoh and Y. Tateno, Psychopharmacology 113 311-7 (1994).
9. U. Andersson, S.-Å. Eckernas, P. Hartvig, J. Ulin, B. Langstrom, and J.E. Haggstrom, J Neural Transm Gen Sect 79 215-26 (1990).
10. D.F. Wong, A. Gjedde and H.N. Wagner, Jr., J Cereb Blood Flow Metab 6 137-46 (1986).
11. S. -C. Lin, K. C. Olson, H. Okazaki, E. Richelson, J Neurochem 46 247-79 (1986)
12. R. Cortes, A. Probst, H.J. Tobler and J.M. Palacios, Brain Res 362 239-53 (1986).
13. J. Votaw, R. Kessler and T. DePaulis, Synapse 15 177-190 (1993).
14. A.L. Nordstrom, L. Farde and C. Halldin, Psychopharmacology 106 433-8 (1992).
15. C. Bench, A. Lammertsma, P. Grasby, R. Dolan, S. Warrington, M. Boyce, K. Gunn, L. Brannick and R. Frackowiak, Psychopharmacology 124 141-147 (1996).
16. R. Grimaldi, E. Perucca, G. Ruberto, C. Gelmi, F. Trimarchi, M. Hollmann and A. Crema, Eur J Clin Pharmacol 29 735-737 (1986).
17. A. Forsman, Proc R Soc Med 69 9-12 (1976).
18. S. Kapur, R. Zipursky, P. Roy, C. Jones, G. Remington, K. Reed and S. Houle, Psychopharmacology 131 148-152 (1997).
19. S. Nyberg, L. Farde, C. Halldin, M.L. Dahl and L. Bertilsson, Am J Psychiatry 152 173-8 (1995).
20. J.-K. Zubieta, R. Koeppe, G. Mulholland, D. Kuhl and K. Frey, J Cereb Blood Flow Metab 18 619-631 (1998).